name,pdb_id,pubmed_id,resolution,uniprot,PFAM,CATH,receptor_chain,receptor_length,peptide_chain,peptide_length,sequence_alignment,stride,percent_exposed_alignment,cluster_number,binding_mode,size_of_binding_mode,core_ecr_alignment,longest_continuous_core,longest_continuous_ecr,corebinding_aa,exosite_aa,surface_aa,interior_aa,corebinding_ss,exosite_ss,surface_ss,interior_ss,unique_id,COREBINDING_aa,COREBINDING_ss,EXOSITE_aa,EXOSITE_ss,bfact,bs_loc_type,full_peptide_sequece,mean_seq_iden_in_bm,mean_seq_iden_not_bm,min_dist_E_C_diff_bm,occupancy,pep_loc_type,title
2H1P_LH_P_127_3.pdb,2H1P,9417940,2.40,,,2.60.40.10,LH,439,P,11,LQYTPSWMLVG,TTBCTTTTTTC,32201320014,127,3,1,CCCCCCCCCCC,11,0,A:0;F:0;H:0;L:0;N:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;F:0;H:0;L:0;N:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:3;C:1;D:9;E:4;G:5;K:14;L:1;M:1;N:4;P:5;Q:1;R:4;S:15;T:6;V:1,A:17;C:8;D:12;E:12;F:15;G:25;H:6;I:11;K:13;L:34;M:4;N:12;P:20;Q:11;R:9;S:48;T:35;V:32;W:7;Y:16,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:18;E:8;G:6;H:5;T:37,B:9;C:59;E:205;G:12;H:7;T:51;b:4,127_3,A:1;F:1;H:2;L:1;N:2;Q:1;R:1;S:3;T:2;V:1;W:1;Y:2,B:1;C:1;E:4;T:12,A:0;F:0;H:0;L:0;N:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;T:0,77766666777,ALA_103_H_COREBINDING;ARG_99_H_COREBINDING;ASN_33_L_COREBINDING;ASN_52_H_COREBINDING;GLN_27_L_COREBINDING;HIS_31_L_COREBINDING;HIS_98_L_COREBINDING;LEU_105_H_COREBINDING;PHE_33_H_COREBINDING;SER_101_H_COREBINDING;SER_32_L_COREBINDING;SER_96_L_COREBINDING;THR_50_H_COREBINDING;THR_97_L_COREBINDING;TRP_101_L_COREBINDING;TYR_37_L_COREBINDING;TYR_59_H_COREBINDING;VAL_99_L_COREBINDING,GLQYTPSWMLVG,-1,0.392938496583144,,99999999999,LEU_1_P_C;GLN_2_P_C;TYR_3_P_C;THR_4_P_C;PRO_5_P_C;SER_6_P_C;TRP_7_P_C;MET_8_P_C;LEU_9_P_C;VAL_10_P_C;GLY_11_P_C,"THE THREEDIMENSIONAL STRUCTURES OF A POLYSACCHARIDE 2 BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS 3 COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY 4 IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES"
3MLX_IM_Q_127_1.pdb,3MLX,20622876,1.90,,,2.60.40.10,IM,437,Q,14,KRIHIGPGRAFYTT,CCEEETTTTCCCCC,51110011221224,127,1,1,CCCCCCCCCCCCCC,14,0,D:0;E:0;F:0;G:0;L:0;M:0;N:0;R:0;S:0;Y:0,D:0;E:0;F:0;G:0;L:0;M:0;N:0;R:0;S:0;Y:0,A:4;D:2;E:1;G:11;H:1;K:9;N:2;P:6;Q:4;R:3;S:24;T:7,A:23;C:9;D:9;E:14;F:10;G:27;H:6;I:12;K:13;L:31;M:1;N:10;P:24;Q:15;R:7;S:44;T:32;V:36;W:8;Y:15,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,B:1;C:20;E:6;G:8;H:7;T:32,B:6;C:59;E:208;G:10;H:10;T:49;b:4,127_1,D:1;E:2;F:2;G:2;L:1;M:1;N:1;R:1;S:1;Y:5,B:1;C:1;E:8;T:7,D:0;E:0;F:0;G:0;L:0;M:0;N:0;R:0;S:0;Y:0,B:0;C:0;E:0;T:0,99765555556799,ARG_97_I_COREBINDING;ASN_30_M_COREBINDING;ASP_115_I_COREBINDING;GLU_101_I_COREBINDING;GLU_50_M_COREBINDING;GLY_100_I_COREBINDING;GLY_31_I_COREBINDING;LEU_46_M_COREBINDING;MET_32_M_COREBINDING;PHE_32_I_COREBINDING;PHE_99_I_COREBINDING;SER_30_I_COREBINDING;TYR_102_I_COREBINDING;TYR_104_I_COREBINDING;TYR_49_M_COREBINDING;TYR_52_I_COREBINDING;TYR_53_I_COREBINDING,YNKRKRIHIGPGRAFYTTKNIIG,-1,0.260311817475748,,99999999999999,LYS_1_Q_C;ARG_2_Q_C;ILE_3_Q_C;HIS_4_Q_C;ILE_5_Q_C;GLY_6_Q_C;PRO_7_Q_C;GLY_8_Q_C;ARG_9_Q_C;ALA_10_Q_C;PHE_11_Q_C;TYR_12_Q_C;THR_13_Q_C;THR_14_Q_C,"CRYSTAL STRUCTURE OF ANTIHIV1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 2 PEPTIDE"
4GW5_CD_F_127_2.pdb,4GW5,24101516,2.20,,,2.60.40.10,CD,428,F,12,CQYNLSSRALKC,CEEETTTTEEEC,120101010022,127,2,1,CCCCCCCCCCCC,12,0,A:0;D:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;V:0;Y:0,A:0;D:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;V:0;Y:0,A:2;D:3;E:3;G:8;K:10;L:2;N:5;P:3;Q:2;R:1;S:22;T:5;Y:2,A:17;C:8;D:11;E:12;F:16;G:22;H:6;I:13;K:11;L:31;M:1;N:16;P:17;Q:19;R:10;S:41;T:27;V:34;W:8;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,C:20;E:9;G:8;H:3;T:28,B:7;C:55;E:194;G:10;H:8;T:56;b:6,127_2,A:3;D:1;E:1;G:2;I:2;K:1;L:1;N:1;P:3;Q:2;R:1;S:1;T:3;V:1;Y:1,C:7;E:11;T:6,A:0;D:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;V:0;Y:0,C:0;E:0;T:0,998889888899,ALA_100_C_COREBINDING;ALA_170_D_COREBINDING;ALA_91_D_COREBINDING;ARG_39_C_COREBINDING;ASN_41_C_COREBINDING;ASP_85_C_COREBINDING;GLN_38_C_COREBINDING;GLN_39_D_COREBINDING;GLU_165_C_COREBINDING;GLY_101_C_COREBINDING;GLY_42_D_COREBINDING;ILE_10_C_COREBINDING;ILE_92_D_COREBINDING;LEU_114_D_COREBINDING;LYS_103_C_COREBINDING;PRO_151_D_COREBINDING;PRO_169_D_COREBINDING;PRO_41_D_COREBINDING;SER_40_D_COREBINDING;THR_102_C_COREBINDING;THR_40_C_COREBINDING;THR_90_D_COREBINDING;TYR_87_C_COREBINDING;VAL_9_C_COREBINDING,CQYNLSSRALKC,-1,0.409514550960942,,999999999999,CYS_1_F_C;GLN_2_F_C;TYR_3_F_C;ASN_4_F_C;LEU_5_F_C;SER_6_F_C;SER_7_F_C;ARG_8_F_C;ALA_9_F_C;LEU_10_F_C;LYS_11_F_C;CYS_12_F_C,"CQYN MEDITOPE CETUXIMAB FAB"
